First, we demonstrated that the pancreatic cancer cell line AsPC-1 highly expressed the integrin αvβ3 and MSLN, and the target cells were genetically engineered to express the red fluorescent protein (RFP) (Additional file 1: Figure S9a-S9c). This evidence concerns the gene MSLN and familial pancreatic carcinoma.